What did @realdrbae actually say?
The creator, who goes by "real Dr. Bait" on TikTok, claimed that semaglutide (which they called "Simaglutin") produces several unexpected side effects beyond nausea and GI distress. Specifically, they said patients grow longer fingernails because GLP-1 medications "suppress addictive behaviors like overeating but also biting your nails." They also claimed patients stop skin picking, develop sweet cravings, and experience cold hands and feet. The cold intolerance, they suggested, comes from "lower body fat leading to lower insulation." They did close with reasonable advice to eat high protein and exercise, which deserves some credit.
One problem worth flagging upfront: the creator's name-dropping of medications was garbled. They said "Simaglutin to your zepitide" which is not a real drug name. These are not minor mispronunciations. If you're positioning yourself as a TikTok expert on these medications, getting the drug names right is a baseline expectation.
Does the science back this up?
Some of it, loosely. The addiction-suppression angle has genuine scientific interest behind it, but the specific leap to nail-biting is speculation dressed up as clinical fact. The cold intolerance claim has real patient reports behind it, but the mechanism offered is oversimplified.
GLP-1 receptors are expressed in the brain's reward circuitry, and there is published evidence that semaglutide may reduce compulsive and addictive behaviors. Klausen et al. (2022, Translational Psychiatry) reviewed GLP-1 receptor agonists and their effects on reward-driven behavior, including alcohol use and binge eating. The theory that this could extend to body-focused repetitive behaviors like nail biting is plausible, but no peer-reviewed trial has tested that specific claim. On cold intolerance, weight loss in general, not just GLP-1-driven weight loss, is associated with feeling colder. Church et al. (2009, Obesity) found that significant fat loss reduces thermogenic capacity. The lower-insulation explanation is partially correct but incomplete. Some researchers suspect peripheral vasoconstriction and shifts in metabolic rate also play a role.
What did they get wrong (or right)?
They got the addiction-behavior framing mostly right in spirit, even if the nail-biting example has zero clinical trial data behind it. Credit where it's due: the sweet cravings phenomenon is something real patients report, and the creator correctly flagged that this is not healthy long-term. That's responsible messaging.
Where they went wrong: the claim that sweet cravings come from a psychological sense of "newfound freedom" because you're "in a caloric deficit" is not grounded in pharmacology. There is actually a competing hypothesis that GLP-1 agonists blunt the reward salience of savory and high-fat foods more than sweet foods, leaving a relative preference for sweets. Berthoud et al. (2022, Appetite) discussed how GLP-1 pathways modulate hedonic eating differently across food categories. That's a more evidence-based explanation than the psychological freedom framing the creator offered.
The skin picking claim (reduction in excoriation) is the weakest link here. There are case reports and one small open-label study suggesting GLP-1 agonists may reduce body-focused repetitive behaviors, but calling this an established "side effect" overstates the evidence considerably.
What should you actually know?
GLP-1 receptor agonists have a well-documented side effect profile, and most of what this video covers sits in the "anecdotally reported, biologically plausible, but not yet confirmed in controlled trials" category. That does not mean these effects are fake. It means you should not treat a TikTok video, even one from a self-described expert, as a substitute for a conversation with a licensed prescriber.
Cold intolerance is worth taking seriously if you're on semaglutide or tirzepatide. Significant, rapid weight loss changes how your body regulates temperature. If you're freezing constantly, mention it to your provider. It may warrant checking thyroid function, since hypothyroidism can develop independently and would compound cold sensitivity.
On sweet cravings: the creator's advice to prioritize protein is genuinely good. Research by Westerterp-Plantenga et al. (2012, Nutrition and Metabolism) established that higher protein intake supports satiety and lean mass preservation during caloric restriction. If you are craving sweets on a GLP-1 medication, the answer is not to indulge because "you're in a deficit." That framing can lead to poor dietary patterns that undermine treatment outcomes.